Standard Life Aberdeen »

Harpoon Therapeutics shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Harpoon Therapeutics shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Harpoon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Harpoon Therapeutics held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Harpoon Therapeutics by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2023-12-31 $296k 26k 11.37

More positions owned by Standard Life Aberdeen

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Merck & Co (MRK)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)

View all positions for Standard Life Aberdeen

Top funds holding Harpoon Therapeutics

Cormorant Asset Management
Commodore Capital
RA Capital Management
Franklin Resources
Artal Group
Vanguard Group
Soleus Capital Management
Blackstone Group
Citadel Advisors
Lion Point Capital
Kennedy Capital Management
Goldman Sachs Group
Citigroup
Two Sigma Investments
Standard Life Aberdeen

View all funds holding Harpoon Therapeutics